Jussi Lehto
Publications
- Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis2025
- Nature MedicineSpringerPlus
(A1 Refereed original research article in a scientific journal) - Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosisApplication of cross-species PET imaging to assess neurotransmitter release in brain (2025)
- Journal of Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)
- Journal of Neurology, Neurosurgery and Psychiatry
(A1 Refereed original research article in a scientific journal) - Imaging of a2C-adrenoceptors in the living brain: a method to monitor noradrenaline release?2025
- Neurology, Neuroimmunology and NeuroinflammationSynapse
(A1 Refereed original research article in a scientific journal) - (2024)
- EJNMMI Research
(A1 Refereed original research article in a scientific journal) - (2024)
- Multiple Sclerosis
(Abstract) - TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patientsValidation of [11C]ORM-13070 as a PET tracer for alpha2c-adrenoceptors in the human brain (2024)
- Multiple Sclerosis
(Poster) - Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)
- European Journal of NeurologyJournal of NeurologyPsychopharmacology
(A1 Refereed original research article in a scientific journal) - PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)
(B1 Non-refereed article in a scientific journal) - The effect of an apple polyphenol extract rich in epicatechin and flavan-3-ol oligomers on brachial artery flow-mediated vasodilatory function in volunteers with elevated blood pressure (2017)
- Nutrition Journal
- Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the α2C-adrenoceptor PET ligand [11C]ORM-13070The alpha2C-adrenoceptor as a neuropsychiatric drug tar-get - PET studies in human subjects (2016)
- Synapse
(A1 Refereed original research article in a scientific journal) - (2015)
- Psychopharmacology
(A2 Refereed review article in a scientific journal ) - (2015)
(Other publication) - Sensitivity of [C-11]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjects (2015)
(A1 Refereed original research article in a scientific journal) - Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain (2015)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Refereed original research article in a scientific journal) - (2015) Lehto Jussi
(G5 Article dissertation ) - (2015)
(A1 Refereed original research article in a scientific journal)